Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

DTC Animation Study Moving Forward After FDA Rejects Merck Critique

Executive Summary

Merck contends FDA's study of animation in drug ads may be ‘unnecessary for the proper performance of FDA’s functions’ but agency says it could influence policy.

Advertisement

Related Content

Twitter Rx Drug Promos: FDA Studies Best Way To Convey Risk Info
DTC Safety Messages Could Vary By Platform As FDA Considers Screen Size
DTC Rx Drug Ad Study No. 30: Do Market Claims Impact Perception?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register